We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

1 hedge funds and large institutions have $0 invested in AMAG Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 113 → 1 (-112)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $348M → $0 (-$348M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 112

Holders
1
Holders Change
-112
Holders Change %
-99.12%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
112
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$49.3M
2
CCM
Camber Capital Management
Massachusetts
-$41.3M
3
AC
Armistice Capital
New York
-$38.7M
4
PAI
Palo Alto Investors
California
-$28.2M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$27.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
– -$49.3M -5,250,023 Closed
CCM
2
Camber Capital Management
Massachusetts
– -$41.3M -4,390,000 Closed
AC
3
Armistice Capital
New York
– -$38.7M -4,120,000 Closed
PAI
4
Palo Alto Investors
California
– -$28.2M -3,003,875 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
– -$27.1M -2,877,512 Closed
Goldman Sachs
6
Goldman Sachs
New York
– -$19M -2,021,177 Closed
Renaissance Technologies
7
Renaissance Technologies
New York
– -$17M -1,809,400 Closed
State Street
8
State Street
Massachusetts
– -$12.3M -1,309,753 Closed
BL
9
Bleichroeder LP
New York
– -$12.2M -1,299,994 Closed
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
– -$10.3M -1,093,639 Closed
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
– -$9.35M -994,916 Closed
Bank of America
12
Bank of America
North Carolina
– -$8.67M -922,172 Closed
Jacobs Levy Equity Management
13
Jacobs Levy Equity Management
New Jersey
– -$7.21M -767,135 Closed
Morgan Stanley
14
Morgan Stanley
New York
– -$5.69M -605,625 Closed
Geode Capital Management
15
Geode Capital Management
Massachusetts
– -$4.64M -494,234 Closed
Northern Trust
16
Northern Trust
Illinois
– -$4.14M -440,483 Closed
Bank of New York Mellon
17
Bank of New York Mellon
New York
– -$3.38M -359,863 Closed
PC
18
Permanens Capital
New York
– -$3.38M -359,311 Closed
BFM
19
Boothbay Fund Management
New York
– -$3.27M -348,000 Closed
Invesco
20
Invesco
Georgia
– -$2.81M -298,564 Closed
Principal Financial Group
21
Principal Financial Group
Iowa
– -$2.1M -223,935 Closed
Ameriprise
22
Ameriprise
Minnesota
– -$2M -212,667 Closed
Assenagon Asset Management
23
Assenagon Asset Management
Luxembourg
– -$1.96M -208,261 Closed
Charles Schwab
24
Charles Schwab
California
– -$1.89M -201,352 Closed
Norges Bank
25
Norges Bank
Norway
– -$1.86M -197,716 Closed
1
2 3 4 5

AMAG Hedge Fund Activity: Q4 2020 in Review

1 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q4 2020, worth a combined $0 — down 100% from $348M a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of AMAG and 0 opened new positions — a net loss of 112 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $49.3M sold.

  • 1 institutional investor held AMAG Pharmaceuticals (AMAG) as of Q4 2020, down from 113 in Q3 2020.
  • Funds reported $0 of AMAG Pharmaceuticals stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new AMAG Pharmaceuticals positions in Q4 2020 and 112 closed out, a net change of -112 holders.
  • The largest AMAG Pharmaceuticals seller in Q4 2020 was BlackRock, an estimated $49.3M sold.

Based on aggregated 13F filings for Q4 2020.